Your browser doesn't support javascript.
loading
Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis.
Kim, Manse; Sahu, Abhishek; Kim, Gi Beom; Nam, Gi Hoon; Um, Wooram; Shin, So Jin; Jeong, Yong Yeon; Kim, In-San; Kim, Kwangmeyung; Kwon, Ick Chan; Tae, Giyoong.
Afiliación
  • Kim M; School of Materials Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.
  • Sahu A; School of Materials Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.
  • Kim GB; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea; KU-KIST School of Converging Science and Technology, Korea University, Seoul, Republic of Korea.
  • Nam GH; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea; KU-KIST School of Converging Science and Technology, Korea University, Seoul, Republic of Korea.
  • Um W; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06351, Republic of Korea.
  • Shin SJ; Department of Radiology, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Gwangju 61469, Republic of Korea.
  • Jeong YY; Department of Radiology, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Gwangju 61469, Republic of Korea.
  • Kim IS; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea; KU-KIST School of Converging Science and Technology, Korea University, Seoul, Republic of Korea.
  • Kim K; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea; KU-KIST School of Converging Science and Technology, Korea University, Seoul, Republic of Korea.
  • Kwon IC; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea; KU-KIST School of Converging Science and Technology, Korea University, Seoul, Republic of Korea.
  • Tae G; School of Materials Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea. Electronic address: gytae@gist.ac.kr.
J Control Release ; 269: 337-346, 2018 01 10.
Article en En | MEDLINE | ID: mdl-29175140
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Portadores de Fármacos / Compuestos Férricos / Aterosclerosis / Nanopartículas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2018 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Portadores de Fármacos / Compuestos Férricos / Aterosclerosis / Nanopartículas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2018 Tipo del documento: Article Pais de publicación: Países Bajos